TELEDERMATO: Teledermatology Versus Usual Care on Delay Before Diagnosis and Treatment of Dermatologic Conditions

Sponsor
University Paris 7 - Denis Diderot (Other)
Overall Status
Completed
CT.gov ID
NCT02122432
Collaborator
(none)
109
1
2
9
12.1

Study Details

Study Description

Brief Summary

In France, there is usually a long delay (approximately 6 weeks) before a general practitioner can obtain a specialized advice by dermatologists for diagnosis of "unusual" dermatologic conditions of their patients.

Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.

We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Teledermatology
N/A

Detailed Description

In France, there is usually a long delay (approximately 6 weeks) before a general practitioner can obtain a specialized advice by dermatologists for diagnosis of "unusual" dermatologic conditions of their patients.

Previous studies have shown that teledermatology is a reliable way for diagnosis in dermatology.

We hypothesize that a teledermatology advice could reduce delay before diagnosis and therefore treatment for patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
109 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Impact of Teledermatology Versus Usual Care on Delay Before Diagnosis and/or Treatment of Dermatologic Conditions in General Practice
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Jan 1, 2015
Actual Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Teledermatology

General practitioner takes 3 photographs per dermatologic lesion using either a telephone with a 3Mega Pixel minimum camera or a standard camera following recommendations of the practice guidelines for teledermatology (2007) of the American Telemedicine Association and sends them to the dermatologist using a secured email server. Dermatologist answer is standardized.

Other: Teledermatology
General practitioner takes 3 photographs per dermatologic lesion using either a telephone with a 3Mega Pixel minimum camera or a standard camera following recommendations of the practice guidelines for teledermatology (2007) of the American Telemedicine Association. Photographs are sent by email using a secured mail server with at least the following information=date of symptoms, symptomatology, topography of lesions, description of lesions, extension, recent drug intakes) Photographs are read and analyzed by a single dermatologist who gives an expert answer (diagnosis and/or treatment). Answer is sent back to the general practitioner by email (using a secured mail server). Answer contains at least the following information= are photographs usable? What is the diagnosis? If necessary, which treatment should the general practitioner begin ? If necessary, does the patient need a consultation with a dermatologist ?

No Intervention: Usual care

Usual care for dermatologic conditions requiring an expertise from a dermatologist involves the general practitioner 1) giving the patient a paper letter containing at least the following information: date of symptoms, symptomatology, topography of lesions, description of lesions, extension, recent drug intakes) and 2) telling him to see the dermatologist of his choice (patient manages his appointments alone).

Outcome Measures

Primary Outcome Measures

  1. Delay before expertise by a dermatologist [3 months]

    Delay, in days, between a patient's consultation with his general practitioner and expertise by a dermatologist (teledermatology or classic consultation) that allows either diagnostic and/or initiation of treatment. For example: in the teledermatology group, if the specialist needs to see the patient because the photographs cannot be analyzed correctly, date of expertise is the date of the consultation with the dermatologist. Data is censured after 3 months.

Secondary Outcome Measures

  1. Patient's satisfaction [1 month after expertise by dermatologist]

    An investigator will call patients by telephone and assess their satisfaction with their care for the dermatologic condition using a simple rating scale with 4 items ranging from "Not satisfied" (1) to "very satisfied" (4).

Other Outcome Measures

  1. Physicians satisfaction with teledermatology [3 months]

    questionnaire at the end of the study using simple rating scales ranging from "Not satisfied" (1) to "very satisfied" (4)

  2. Number of non usable photographs in teledermatology group [3 months]

    Number of non usable photographs in teledermatology group. Assessment by dermatologists who received the photograph. Reasons for non usability

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Consultation with a general practitioner for any motive during which, the general practitioner deems necessary to obtain a dermatologic expertise for a skin lesion (for diagnosis or treatment)
Exclusion Criteria:
  • Emergency, assessed by the general practitioner (needs care or quick telephonic advice in the next 24 hours)

  • Patients for which diagnosis and/or treatment are known by the general practitioner (the GP needs a dermatologic advice for a specific treatment (for example= laser, instrumental treatment...))

  • Patient cannot go the dermatologic consultation by himself (for example: dependant patients...)

  • Cognitive or psychiatric impairment (cannot give informed consent)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University paris Diderot Paris France

Sponsors and Collaborators

  • University Paris 7 - Denis Diderot

Investigators

  • Principal Investigator: Viet Thi Tran, MD, University paris Diderot

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TRAN Viet thi, MD, University Paris 7 - Denis Diderot
ClinicalTrials.gov Identifier:
NCT02122432
Other Study ID Numbers:
  • DMG002
First Posted:
Apr 24, 2014
Last Update Posted:
Jun 22, 2015
Last Verified:
Jun 1, 2015
Keywords provided by TRAN Viet thi, MD, University Paris 7 - Denis Diderot
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2015